Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

The Effect of Surfactant Administration on Cerebral Oxygenation

N/ASuspendedNCT01258517
Zekai Tahir Burak Women's Health Research and Education Hospital40 enrolled

Overview

The purpose of this study is to assess changes in cerebral oxygenation during two different types (beractant and poractant) and two different routes (double lumen or single lumen endotracheal tube) of surfactant administration using near infrared spectroscopy (NIRS).

Study Type

OBSERVATIONAL

Enrollment

40

Conditions

Respiratory Distress SyndromePrematurity

Interventions

near infrared spectroscopy (INVOS 5100)DEVICE

monitorization of cerebral oxygenation by INVOS 5100 during surfactant administration

Eligibility

Sex: ALLMin age: 23 WeeksMax age: 32 Weeks
Medical Language ↔ Plain English
Inclusion Criteria: Clinical diagnosis of respiratory distress syndrome \<32 gestational weeks and/or \<1500 g birthweight Exclusion Criteria: major congenital anomalies complex congenital heart diseases

Locations (1)

Zekai Tahir Burak Maternity Teaching Hospital, Neonatal Intensive Care Unit

Ankara, Turkey (Türkiye)

Outcomes

Primary Outcomes

to determine the optimal and the most safe surfactant administration technique with regard to cerebral oxygenation as measured by near infrared spectroscopy in low birth weigh infants

Time frame: up to 36 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.